LEXARIA BIOSCIENCE CORP. Foreign Currency Transaction Gain (Loss), Unrealized
LEXARIA BIOSCIENCE CORP. (LEXX) reported Foreign Currency Transaction Gain (Loss), Unrealized of $0 for the 3-month period ending 2022-11-30, per its 10-Q/A filed 2023-01-18.
Discontinued › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossUnrealized · last filed 2023-01-18
- LEXARIA BIOSCIENCE CORP. foreign currency transaction gain (loss), unrealized for the quarter ending 2022-11-30 was $0.00, a 100.00% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. foreign currency transaction gain (loss), unrealized for the quarter ending 2021-11-30 was $109.00.
- LEXARIA BIOSCIENCE CORP. foreign currency transaction gain (loss), unrealized for the quarter ending 2020-11-30 was -$182.00.
- LEXARIA BIOSCIENCE CORP. foreign currency transaction gain (loss), unrealized for the quarter ending 2014-07-31 was $0.00, a 100.00% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. foreign currency transaction gain (loss), unrealized for fiscal 2018 was -$602.00.
- LEXARIA BIOSCIENCE CORP. foreign currency transaction gain (loss), unrealized for fiscal 2013 was -$19.29K.
- LEXARIA BIOSCIENCE CORP. foreign currency transaction gain (loss), unrealized for fiscal 2012 was -$1.08K.
- LEXARIA BIOSCIENCE CORP. foreign currency transaction gain (loss), unrealized for fiscal 2011 was -$52.82K.
| Period end | Foreign Currency Transaction Gain (Loss), Unrealized 3 month | Foreign Currency Transaction Gain (Loss), Unrealized 6 month | Foreign Currency Transaction Gain (Loss), Unrealized 9 month | Foreign Currency Transaction Gain (Loss), Unrealized 10 month | Foreign Currency Transaction Gain (Loss), Unrealized 12 month | Foreign Currency Transaction Gain (Loss), Unrealized 12 month as first filed |
|---|---|---|---|---|---|---|
| 2022-11-30 | $0.00 10-Q/A · filed 2023-01-18 | |||||
| 2021-11-30 | $109.00 10-Q/A · filed 2023-01-18 | |||||
| 2020-11-30 | -$182.00 10-Q · filed 2021-01-14 | |||||
| 2018-08-31 | -$602.00 10-K · filed 2019-11-14 | |||||
| 2016-02-29 | $0.00 10-Q · filed 2016-04-13 | |||||
| 2015-02-28 | $0.00 10-Q · filed 2016-04-13 | |||||
| 2014-08-31 | $0.00 10-KT · filed 2014-12-09 | |||||
| 2014-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$41.87K derived: sum of 2 quarters · filed 2014-11-14 | $0.00 10-Q · filed 2014-11-14 | -$26.09K derived: sum of 4 quarters · filed 2014-12-09 | ||
| 2014-04-30 | -$41.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-12 | $0.00 10-Q · filed 2014-06-12 | -$26.09K derived: sum of 3 quarters · filed 2014-12-09 | -$18.02K derived: sum of 4 quarters · filed 2014-12-09 | ||
| 2014-01-31 | $41.87K 10-Q · filed 2014-03-12 | $15.77K derived: sum of 2 quarters · filed 2014-12-09 | $23.84K derived: sum of 3 quarters · filed 2014-12-09 | $24.71K derived: sum of 4 quarters · filed 2014-12-09 | ||
| 2013-10-31 | -$26.09K derived: 10-KT 12 month − 10-Q 9 month · filed 2014-12-09 | -$18.02K derived: sum of 2 quarters · filed 2014-12-09 | -$17.16K derived: sum of 3 quarters · filed 2014-12-09 | -$19.29K 10-KT · filed 2014-12-09 | $0.00 10-K · filed 2014-01-24 | |
| 2013-08-31 | $0.00 10-KT · filed 2014-12-09 | |||||
| 2013-07-31 | $8.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $8.93K derived: sum of 2 quarters · filed 2014-11-14 | $6.80K 10-Q · filed 2014-11-14 | $6.52K derived: sum of 4 quarters · filed 2014-11-14 | ||
| 2013-04-30 | $863.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-12 | -$1.27K 10-Q · filed 2014-06-12 | -$1.54K derived: sum of 3 quarters · filed 2014-06-12 | $8.93K derived: sum of 4 quarters · filed 2014-06-12 | ||
| 2013-01-31 | -$2.13K 10-Q · filed 2014-03-12 | -$2.41K derived: sum of 2 quarters · filed 2014-03-12 | $8.06K derived: sum of 3 quarters · filed 2014-03-12 | -$4.64K derived: sum of 4 quarters · filed 2014-03-12 | ||
| 2012-10-31 | -$275.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-24 | $10.20K derived: sum of 2 quarters · filed 2014-01-24 | -$2.50K derived: sum of 3 quarters · filed 2014-01-24 | -$1.08K 10-K · filed 2014-01-24 | ||
| 2012-07-31 | $10.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-09-10 | -$2.23K derived: sum of 2 quarters · filed 2013-09-10 | -$803.00 10-Q · filed 2013-09-10 | $21.78K derived: sum of 4 quarters · filed 2013-09-10 | ||
| 2012-04-30 | -$12.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-06-12 | -$11.28K 10-Q · filed 2013-06-12 | $11.31K derived: sum of 3 quarters · filed 2013-06-12 | -$16.96K derived: sum of 4 quarters · filed 2013-06-12 | ||
| 2012-01-31 | $1.43K 10-Q · filed 2013-03-13 | $24.01K derived: sum of 2 quarters · filed 2013-03-13 | -$4.25K derived: sum of 3 quarters · filed 2013-03-13 | -$51.40K derived: sum of 4 quarters · filed 2013-03-13 | ||
| 2011-10-31 | $22.59K derived: 10-K 12 month − 10-Q 9 month · filed 2013-01-29 | -$5.68K derived: sum of 2 quarters · filed 2013-01-29 | -$52.82K derived: sum of 3 quarters · filed 2013-01-29 | -$52.82K 10-K · filed 2013-01-29 | ||
| 2011-07-31 | -$28.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-09-12 | -$75.41K derived: sum of 2 quarters · filed 2012-09-12 | -$75.41K 10-Q · filed 2012-09-12 | -$77.27K derived: sum of 4 quarters · filed 2012-09-12 | ||
| 2011-04-30 | -$47.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-06-07 | -$47.14K 10-Q · filed 2012-06-07 | -$49.00K derived: sum of 3 quarters · filed 2012-06-07 | |||
| 2011-01-31 | $0.00 10-Q · filed 2012-03-13 | -$1.86K derived: sum of 2 quarters · filed 2012-03-13 | ||||
| 2010-10-31 | -$1.86K derived: 10-K 12 month − 10-Q 9 month · filed 2012-01-30 | -$23.77K 10-K · filed 2012-01-30 | ||||
| 2010-07-31 | -$21.90K 10-Q · filed 2011-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |